Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others)

  • ID: 4616189
  • Report
  • Region: Global
  • 264 Pages
  • Kalorama Information
1 of 4
The Global Market for Human Vaccines is Experiencing Strong Growth, Fuelled by Favorable Demographics, Continued New Product Introductions, Indication Expansions for Some Products and Rising Usage

FEATURED COMPANIES

  • Bavarian Nordic A/S
  • CSL Limited
  • Emergent Biosolutions
  • Hawaii Biotech
  • Merck & Co. Inc.
  • PaxVax
  • MORE

The global market for human vaccines is experiencing strong growth, fuelled by favorable demographics (population growth, rising life expectancy), continued new product introductions, indication expansions for some products and rising usage, particularly in India and China. Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments examines the market for vaccines used in humans to prevent various types of disease, providing a comprehensive market summary.

Total World Vaccine Market

While vaccines account for only a small portion of the world pharmaceutical market, their growth will continue to strongly outpace that of broader drug market. The report provides a comprehensive world market summary, including:

  • Total World Market for Preventive Vaccines by Type, 2015-2024 (Pediatric Total: Combinations, Hepatitis, HIB, MMR, Pneumococcal, Poliovirus, Varicella, Others; Adult Total: Cervical, Hepatitis, Influenza, Pneumococcal, Travel & Other; Total)
  • Total World Market for Vaccines by Type, 2015-2024 (Pediatric, Adult)
  • World Market for Vaccines Share by Type, 2015 (Pediatric, Adult) (%)
  • World Market for Vaccines Share by Type, 2024 (Pediatric, Adult) (%)

Pediatric Preventative Vaccine Market

The major vaccine-preventable diseases that disproportionately affect children are discussed in the report, along with current products and key products under development. Among the global as well as disease-specific and regional sales data of the pediatric vaccine market presented include the following:

  • World Market for Pediatric Preventive Vaccines by Type (Hep, HiB, MMR, Combinations, Pneumococcal Disease, Polio, Varicella, Others) 2015-2024
  • Market Share of Pediatric Preventative Vaccines by Type, 2017 (Hep, HiB, MMR, Combinations, Pneumococcal Disease, Polio, Varicella, Others) (%)
  • Market Share of Pediatric Preventative Vaccines by Type, 2024 (Hep, HiB, MMR, Combinations, Pneumococcal Disease, Polio, Varicella, Others) (%)
  • World Market for Pediatric Preventative Vaccines by Region (U.S., North America/Caribbean, South America, EU, Japan, India, China, Rest of World) 2015-2024
  • World Pediatric Hepatitis Vaccine Market, 2015-2024
  • World Haemophilus Influenzae Type B (Hib) Vaccine Market, 2015-2024
  • World Measles, Mumps and Rubella (MMR) Vaccine Market, 2015-2024
  • World Pediatric Combination Vaccine Market, 2015-2024
  • World Pediatric Pneumococcal Vaccine Market, 2015-2024
  • World Poliovirus Vaccine Market, 2015-2024
  • World Pediatric Varicella Vaccine Market, 2015-2024
  • World Other Pediatric Vaccine Market, 2015-2024

Adult Preventative Vaccine Market

The major vaccine-preventable diseases that mainly affect adults are discussed in the report, along with current products and key products under development. Among the global as well as disease-specific and regional sales data of the adult vaccine market presented include the following:

  • World Market Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/Other) 2015-2024
  • Market Share of Adult Preventative Vaccines by Type, 2017 (%) (Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel/Other)
  • Market Share of Adult Preventative by Type, 2024 (%) (Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel/Other)
  • World Market for Adult Preventative Vaccines by Region (U.S., North America/Caribbean, South America, EU, Japan, India, China, Rest of World) 2015-2024
  • World Cervical Cancer Vaccine Market, 2015-2024 ($ Millions)
  • World Adult Hepatitis Preventative Vaccine Market, 2015-2024 ($ Millions)
  • World Adult Influenza Preventative Vaccine Market, 2015-2024 ($ Millions)
  • World Adult Pneumococcal Preventative Vaccine Market, 2015-2024 ($ Millions)
  • World Adult Travel and Other Preventative Vaccine Market, 2015-2024 ($ Millions)

Issues and Trends in the Market

Vaccination has played an enormous role in the prevention of disease, having had the greatest impact on human health of any medical intervention to date. As a result, vaccine-preventable diseases and their resulting deaths are now relatively rare in the developed world. However, the developing nations have not benefited as much from the introduction of vaccines. Additionally, other issues are impacting the vaccines industry both positively and negatively. Vaccines 2018 discusses some of the most important macro and micro trends, including:

  • Rising life expectancy;
  • increasing obesity;
  • growing out of pocket spending on healthcare;
  • health insurance changes in the U.S.;
  • decentralization of healthcare services;
  • austerity programs in Europe;
  • global healthcare mergers and acquisitions;
  • vaccine safety challenges and negative public opinion;
  • vaccine shortages;
  • refusal to vaccinate.

Competitive Landscape

The report also discusses the vaccine businesses of industry leaders as well as emerging players with high potential. Many of the larger companies - some active in other areas in addition to vaccines - are discussed, with a focus on their preventative vaccine businesses and products. (Specifically excluded is discussion of related infectious disease products such as therapeutic vaccines and monoclonal antibodies.) An effort has been made to provide the most significant new developments of the important players in the industry, including:

  • Bavarian Nordic A/S
  • Bharat Biotech
  • Crucell /Johnson & Johnson
  • CSL Limited
  • Daiichi Sankyo Co. Ltd.
  • Emergent Biosolutions
  • GlaxoSmithKline
  • Hawaii Biotech
  • Medimmune
  • Merck & Co. Inc.
  • Mymetics
  • PaxVax
  • Pfizer
  • Sanofi Pasteur
  • Serum Institute of India Pvt. Ltd.
  • Soligenix
  • Takeda Pharmaceutical Co. Ltd.
  • Valneva
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bavarian Nordic A/S
  • CSL Limited
  • Emergent Biosolutions
  • Hawaii Biotech
  • Merck & Co. Inc.
  • PaxVax
  • MORE

1. Executive Summary

  • The Global Vaccines Industry
  • Scope and Methodology
  • Market Estimates and Forecasts

2. Introduction to Vaccines

  • Introduction
  • Table Global Morbidity of Vaccine Preventable Diseases in 1990 vs. 2016
  • A Brief History: The Development of Vaccines
  • The Human Immune System
  • Vaccine Mechanism of Action
  • Types of Vaccines
  • Attenuated (Weakened) Live Viruses
  • Table Attenuated Virus Production
  • Killed (Inactivated) Viruses
  • Toxoid Vaccines
  • Genetically Engineered/Modified Vaccines
  • Vaccine Approval Process
  • Table VAERS Table of Reportable Events Following Vaccination

3. Pediatric Preventative Vaccines

  • Introduction
  • Table Global Child Immunization Rates for Vaccines Recommended by the WHO, 2016
  • Childhood Immunization in the United States
  • Table Immunization Profile of the United States - Population by Age Group, Number of Vaccine- Preventable Diseases Reported by Disease, 1990-2014
  • Childhood Immunization Rates
  • Challenges to the Vaccine Delivery System
  • Recommended Childhood Immunization Schedule
  • State Immunization Recommendations
  • United Nations Initiatives
  • Pediatric Vaccine Products
  • Addiction
  • BCG
  • Dengue Fever
  • Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
  • Haemophilus Influenzae Type B
  • Hand, Foot & Mouth Disease
  • Hepatitis A
  • Influenza
  • Measles, Mumps and Rubella
  • Meningococcal Disease
  • Pneumococcal Conjugate
  • Rotavirus
  • Respiratory Syncytial Virus
  • Varicella
  • Pediatric Vaccines in Development
  • Table Selected Pediatric Vaccines in Development, 2018
  • The World Market for Pediatric Preventive Vaccines
  • Total Market Size and Forecast
  • Table World Market for Pediatric Preventive Vaccines by Type (Hep, HiB, MMR, Combinations, Pneumococcal Disease, Polio, Varicella, Others) 2015-2024, in $ Millions
  • Table Growth of World Market for Pediatric Preventative Vaccines by Type (Hep, HiB, MMR, Combinations, Pneumococcal Disease, Polio, Varicella, Others) 2015-2024
  • Table Market Share of Pediatric Preventative Vaccines by Type, 2017 (Hep, HiB, MMR, Combinations, Pneumococcal Disease, Polio, Varicella, Others) (%)
  • Table Market Share of Pediatric Preventative Vaccines by Type, 2024 (Hep, HiB, MMR, Combinations, Pneumococcal Disease, Polio, Varicella, Others) (%)
  • Table World Market for Pediatric Preventative Vaccines by Region (U.S., North America/Caribbean, South America, EU, Japan, India, China, Rest of World) 2015-2024, in $ Millions
  • Table Growth of World Market for Pediatric Preventative Vaccines by Region (U.S., North America/Caribbean, South America, EU, Japan, India, China, Rest of World) 2015-2024
  • Hepatitis Vaccine Market
  • Table World Pediatric Hepatitis Vaccine Market, 2015 - 2024 ($ Millions)
  • Haemophilus Influenzae Type B Vaccine Market
  • Table World Hib Vaccine Market, 2015-2024 ($ Millions)
  • Measles, Mumps and Rubella Vaccines
  • Table World MMR Vaccine Market, 2015-2024 ($ Millions)
  • Combination Vaccines Market
  • Table World Pediatric Combination Vaccine Market, 2015-2024 ($ Millions)
  • Pneumococcal Vaccine
  • Table World Pediatric Pneumococcal Vaccine Market, 2015-2024 ($ Millions)
  • Poliovirus Vaccine
  • Table World Poliovirus Vaccine Market, 2015-2024 ($ Millions)
  • Varicella Vaccines
  • Table World Pediatric Varicella Vaccine Market, 2015-2024 ($ Millions)
  • Other Pediatric Vaccines
  • Table World Other Pediatric Vaccine Market, 2015-2024 ($ Millions)
  • 4. Adult Preventative Vaccines
  • Introduction
  • Global Influenza Surveillance Program
  • U.S. Surveillance
  • Recommended Adult Immunizations
  • Table U.S. Influenza Vaccine Effectiveness, 2004 - 2018 (%)
  • WHO International Health Regulations
  • Adult Vaccine Products
  • BCG
  • Cervical Cancer
  • Table Initiatives to Require HPV Vaccination by U.S. State, 2018
  • Cholera
  • Diphtheria-Tetanus
  • Ebola
  • Hepatitis
  • Influenza
  • Table U.S. Flu Season Severity from 2008 to 2018
  • Table WHO Pandemic Classification Schedule
  • Japanese Encephalitis
  • Nosocomial Infections
  • Pneumococcal Disease
  • Rabies
  • Shingles
  • Typhoid Fever
  • Yellow Fever
  • Adult Vaccines in Development
  • Table Selected Adult Vaccines in Development, 2018
  • The World Market for Adult Preventive Vaccines
  • Total Market Size and Forecast
  • Table World Market Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/Other) 2015-2024, in $ Millions
  • Table Growth of World Market for Adult Preventive Vaccines by Type (Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel/Other) 2015-2024 ($ Millions)
  • Table Market Share of Adult Preventative Vaccines by Type, 2017 (%) (Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel/Other)
  • Table Market Share of Adult Preventative by Type, 2024 (%) (Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel/Other)
  • Table World Market for Adult Preventative Vaccines by Region (U.S., North America/Caribbean, South America, EU, Japan, India, China, Rest of World) 2015-2024, in $ Millions
  • Table Growth of World Market for Adult Preventative Vaccines by Region (U.S., North America/Caribbean, South America, EU, Japan, India, China, Rest of World) 2015-2024 ($ Millions)
  • Cervical Cancer Market
  • Table World Cervical Cancer Vaccine Market, 2015-2024 ($ Millions)
  • Hepatitis Market
  • Table World Adult Hepatitis Preventative Vaccine Market, 2015-2024 ($ Millions)
  • Influenza Vaccine Market
  • Table World Adult Influenza Preventative Vaccine Market, 2015-2024 ($ Millions)
  • Table Estimated World Population by Region and Selected Age Group, 2018, in Millions
  • Pneumococcal Vaccine Market
  • Table World Adult Pneumococcal Preventative Vaccine Market, 2015-2024 ($ Millions)
  • Table U.S. Seasonal Influenza Vaccination by Age Group and Season, 2009-2016
  • Travel and Other Vaccine Market
  • Table World Adult Travel and Other Preventative Vaccine Market, 2015-2024 ($ Millions)

5. Total Vaccines Market

  • Trends Driving the Vaccines Market
  • Table Sales Growth of Vaccines vs. Pharmaceuticals, 2015-2024
  • Market Size and Forecast
  • Table Total World Market for Preventive Vaccines by Type, 2015-2024, in $ Millions
  • Table Total World Market for Vaccines by Type, 2015-2024 (Pediatric, Adult) ($ Millions)
  • Table World Market for Vaccines Share by Type, 2015 (Pediatric, Adult) (%)
  • Table World Market for Vaccines Share by Type, 2024 (Pediatric, Adult) (%)
  • Vaccine Sales by Region
  • Table World Market for Preventative Vaccines by Region (U.S., North America/Caribbean, South America, EU, Japan, India, China, Rest of World) 2015-2024, in $ Millions
  • Vaccine Market Competitors
  • Table Major Manufacturers' Shares of the World Vaccine Market, 2017 (%, $ Millions)
  • Table 2017 World Vaccines Market Share, by Leading Competitors (%)
  • Pediatric Vaccines
  • Table Major Manufacturers' Shares of the World Pediatric Preventative Vaccine Market, 2017 (%, $ Millions)
  • Table 2017 World Pediatric Preventative Vaccines Market Share, by Leading Competitors (%)
  • Adult Vaccines
  • Table Major Manufacturers' Shares of the World Adult Preventative Vaccine Market, 2017 (%, $ Millions)
  • Table 2017 World Adult Preventative Vaccines Market Share, by Leading Competitors (%)

6. Issues and Trends

  • Overview
  • Rising Life Expectancy
  • Increasing Obesity
  • Addiction Epidemic
  • Growing Out of Pocket Spending on Healthcare
  • Health Insurance Changes in the U.S.
  • Affordable Care Act Changes
  • Reimbursement Changes and Value-Based Care
  • Decentralization of Healthcare Services
  • Urgent Care Centers
  • Retail Clinics
  • Austerity Programs in Europe
  • UK
  • Other Nations
  • Global Healthcare Mergers and Acquisitions
  • Table Total U.S. Healthcare M&A Deal Value, 2009-2017, in $ Billions
  • Vaccine Safety
  • Data
  • Refusal to Immunize
  • Table Refusal to Vaccinate Form
  • Post-Licensure Surveillance
  • The Vaccine Injury Compensation Program
  • World Health Organization
  • Other Initiatives
  • Pricing Pressure
  • Cost of Vaccines in the United States
  • Vaccine Shortages
  • Preventing Shortages in the Developed Countries
  • Preventing Shortages in Developing Nations
  • Table R&D on Major Developing Nations Vaccine-Preventable Pathogens, 2018
  • Table Access to Vaccines Index, 2017
  • U.S. National Vaccine Plan
  • Vaccines and Bioterrorism
  • Project Bioshield Act
  • Table Selected Companies/Laboratories Developing Biodefense Vaccines, 2018
  • National Bio and Agro-Defense Facility
  • Vaccine Treatment and Evaluation Units
  • Anthrax
  • Smallpox
  • New Disease Threats
  • Table Vaccine-Preventable Diseases, August 2018
  • Stimulating Vaccine Development
  • Global Health Vaccine Center of Innovation
  • Human Vaccines Project
  • Innovations in Vaccine Delivery Systems
  • Mucosal Delivery
  • Intranasal Delivery
  • Microneedles

7. Company Profiles

  • Bavarian Nordic A/S
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Bharat Biotech
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Crucell /Johnson & Johnson
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • CSL Limited
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Daiichi Sankyo Co. Ltd.
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Emergent Biosolutions
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • GlaxoSmithKline
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Hawaii Biotech
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Medimmune
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Merck & Co. Inc.
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Mymetics
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • PaxVax
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Pfizer
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Sanofi Pasteur
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Serum Institute of India Pvt. Ltd.
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Soligenix
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Takeda Pharmaceutical Co. Ltd.
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Valneva
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bavarian Nordic A/S
  • Bharat Biotech
  • Crucell /Johnson & Johnson
  • CSL Limited
  • Daiichi Sankyo Co. Ltd.
  • Emergent Biosolutions
  • GlaxoSmithKlin
  • Hawaii Biotech
  • Medimmune
  • Merck & Co. Inc.
  • Mymetics
  • PaxVax
  • Pfizer
  • Sanofi Pasteur
  • Serum Institute of India Pvt. Ltd.
  • Soligenix
  • Takeda Pharmaceutical Co. Ltd.
  • Valneva
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll